Lubricin, also commonly referred to as superficial zone protein (SZP) and proteoglycan 4 (PRG4), is a multifaceted, cytoprotective glycoprotein that contributes to the boundary lubrication properties facilitating low friction levels at interfacing surfaces of articular cartilage. Biological processes effecting the gain or loss of lubricin function may therefore have important consequences relevant to joint physiology and pathology. Herein, we describe experiments conducted to extend our understanding of the influence of various cytokines and growth factors on lubricin gene expression and protein secretion in synovial tissues. Exposure of synoviocytes, chondrocytes and cartilage explants to proinflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α) results in a marked reduction in the expression and/or abundance of secreted lubricin, with corresponding alterations in the amounts of cartilage-associated (boundary) lubricin. Conversely, treatment with transforming growth factor-β (TGF-β) significantly upregulates lubricin synthesis, secretion and cartilage boundary association. Oncostatin M also appears to be capable of modulating lubricin metabolism, with the potential to induce lubricin synthesis by chondrocytes. Collectively, the results of studies on cytokine and growth factor regulation of lubricin biosynthesis and biodistribution may help provide new insights and therapeutic perspectives for promoting joint function.
Introduction
Optimal functionality of synovial joints is dependent upon the maintenance of extremely low coefficients of friction between load-accommodating cartilage bearings (Charnley, 1960; Wright and Dowson, 1976) . Under normal, healthy conditions, articular cartilage is a resilient biomaterial that sustains a contiguous, well-lubricated surface. However, during degenerative joint diseases such as osteoarthritis (OA), deleterious structural changes are manifested, including progressive cartilage matrix degradation and fibrillation (Buckwalter et al., 2005) . Lubricin is a chondroprotective, mucinous glycoprotein which is a product of the proteoglycan 4 (PRG4) gene (HGNC:9364) , and is homologous to molecules referred to as superficial zone protein (SZP), megakaryocyte stimulating factor (MSF) precursor, camptodactylyarthopathy-coxa vara-pericarditis (CACP) protein, 'downstream of the liposarcoma-associated fusion oncoprotein' 54 (DOL54) and PRG4 (Flannery et al., 1999; Ikegawa et al., 2000; Jay et al., 2001; Kuroda et al., 1999; Marcelino et al., 1999) . Comprised of a multidomain core protein extensively substituted with β-(1-3)-Gal-GalNAc oligosaccharides partially capped with NeuAc (Garg and Swann, 1979; Jay et al., 2002) , lubricin is a component of synovial fluid which has also been localized to cartilage surfaces and surface layer articular chondrocytes and synoviocytes (Flannery et al., 1999; Schumacher et al., 1994; Schumacher et al., 1999; Su et al., 2001) , meniscus (Schumacher et al., 2005) and tendon (Rees et al., 2002; Sun et al., 2006) . Lubricin acts as a vital counteragent against aberrant protein and/or cellular adhesion, infiltration and overproliferation, and serves as a critical boundary lubricant between apposing cartilage surfaces (Jay, 2004; Rhee et al., 2005) , such that alterations in its metabolism may profoundly impact joint function. Indeed, genetic disruption of lubricin expression elicits CACP syndrome in humans, with attendant non-inflammatory synovial hyperplasia and fibrosis and premature joint failure (Marcelino et al., 1999) , and key features of CACP are recapitulated in lubricin-null mice (Rhee et al., 2005) . Furthermore, impaired lubricin expression is associated with the onset of early OA in a sheep meniscectomy model (Young et al., 2006) .
An increased understanding of the effects of chondrostimulatory growth factors and cytokines on lubricin expression may help provide an enhanced appreciation of the biological processes governing joint homeostasis and pathophysiology. The proinflammatory cytokine IL-1 has been shown to reduce the expression/ secretion of cartilage-derived lubricin (Flannery et al., 1999; Jones et al., 2006; Khalafi et al., 2007; Ohno et al., 2006; Schmidt et al., 2004a) , whereas TGF-β conversely ARC Jones et al. Lubricin bioregulation by growth factors/cytokines causes an upregulation of lubricin synthesis (Darling and Athanasiou, 2005; Flannery et al., 1999; Jones et al., 2006; Khalafi et al., 2007; Ohno et al., 2006; Schmidt et al., 2004a) . In the current studies, we have confirmed and expanded on these findings by examining the effects of a variety of cytokines and growth factors, including IL-1β, TNF-α, TGF-β and oncostatin M (OSM), on lubricin mRNA and protein expression by articular chondrocytes and synoviocytes. Moreover, we evaluated the effects of these cytoregulatory factors on the biosynthesis/ distribution of both soluble and boundary (cartilage surface-associated) lubricin.
Materials and Methods
Cartilage explant culture and analysis Bovine articular cartilage cores (6mm-diameter) were harvested from the carpal joints of 1-2 week old calves using a biopsy punch. Subchondral bone was trimmed from the cores using a custom stainless steel die, creating explants with a depth of 2-3mm. Cartilage explants were precultured in spinner flasks for 4 days in serum-free DMEM/F12 culture medium (Invitrogen, Carlsbad, CA) containing 50 µg/ml ascorbic acid (Sigma, St. Louis, MO), with a change of medium after 2 days. Explants were then transferred to 24 well plates (3 explants/well in 1ml of serum-free culture medium) and cultured for 48h (± 50 µg/ml ascorbic acid) in the absence or presence of 10 ng/ ml IL-1β, 10 ng/ml TGF-β1, 100 ng/ml TNF-α, 10 ng/ml OSM (R&D Systems, Minneapolis, MN) or 1µM all-trans retinoic acid (RA; Sigma). Following tissue culture, explant-conditioned media were concentrated using Centricon YM-10 filter units (Millipore, Billerica, MA), adjusted to 50mM Tris-acetate, pH 7.4, and incubated at 37°C for 1h with chondroitinase ABC (0.3U/ml; Sigma). For analysis of surface/boundary layer-associated lubricin (Jones et al., 2006a) , explants were extracted at 4°C for 1h with PBS containing 1.5M NaCl, then dialysed exhaustively against dH 2 O and lyophilyzed. Extracts and media samples were separated on 4-12% Tris-glycine SDS-PAGE gels (Invitrogen), transferred to Protran BA85 membranes (Whatman, Florham Park, NJ) and analyzed by Western blotting using anti-lubricin monoclonal antibody 6-A-1 (Flannery et al., 1999; Schumacher et al., 1999) , raised against native bovine lubricin/SZP (generously provided by Dr. C.E. Hughes and Prof. B. Caterson, Cardiff University, Cardiff, UK).
Chondrocyte and synoviocyte culture and analysis
Full-depth articular chondrocytes were isolated from normal (non-OA) human articular cartilage (NDRI, Philadelphia, PA) or bovine calf articular cartilage by standard pronase/collagenase digestion (Flannery et al., 1999; Schumacher et al., 1999) . Normal (non-OA) human synoviocytes were purchased from Articular Engineering, Northbrook, IL. Following equilibration for 48h in culture medium (DMEM/F12 containing 10% fetal bovine serum and 50 µg/ml ascorbate) in 24 well plates, cells were adapted to serum-free medium (± 50 µg/ml ascorbate) for 16h before stimulation with cytokines/growth factors (as described above for cartilage explant cultures). RNA was extracted in triplicate (RNeasy + DNAse I, Qiagen, Valencia, CA) after 24h for quantitative, real-time RT-PCR analysis (ABI PRISM 7700 Sequence Detection System; Applied Biosystems, Foster City, CA). For bovine samples, assays were performed using primer/probe sets specific for bovine lubricin (Grad et al., 2005) and GAPDH (Wong et al., 2003) . Human samples were analyzed using TaqMan® gene expression assays (Applied Biosystems) specific for human lubricin (Hs00195140_m1, targeting exons 3/4 or Hs00981633_m1, targeting exons 7/8) and GAPDH (Hs99999905_m1). Lubricin mRNA levels were normalized to GAPDH and expressed relative to control (untreated) culture levels (∆∆C T method; Applied Biosystems). Human chondrocyte or synoviocyte conditioned media were harvested after 48h and analyzed by Western blotting using a polyclonal anti-lubricin antibody (Wyeth Ab 378), directed toward a peptide epitope encoded within exon 3 of human lubricin.
Results
Effects of cytokine and growth factor treatment on lubricin synthesis by bovine cartilage explants Stimulation of cultured calf articular cartilage explants with IL-1β, TGF-β, TNF-α, RA or OSM induced quantitative alterations in the retention of lubricin at the cartilage Figure 1 . Effects of cytokines and growth factors on cartilage lubricin biosynthesis. Bovine articular cartilage explants were cultured for 48h in serum-free medium (+ 50 µg/ml ascorbic acid) in the absence (C, control) or presence of 10 ng/ml IL-1 (IL-1), 10 ng/ml TGF-β1 (TGF), 100 ng/ml TNF-α (TNF), 1µM all-trans retinoic acid (RA) or 10 ng/ml oncostatin M (OSM). Cartilage surface-associated lubricin (A) or soluble lubricin in conditioned media (B) were analyzed by Western blotting with monoclonal antibody 6-A-1, raised against native bovine lubricin/SZP. Lubricin bioregulation by growth factors/cytokines surface, as shown in Fig. 1A . TGF-β and OSM increased lubricin accumulation, whereas a decrease was seen following treatment with IL-1β , TNF-α and RA. A similar lubricin biosynthetic profile was observed for explantconditioned media (Fig. 1B) . Exclusion of ascorbic acid from the culture media lowered the levels of soluble lubricin in conditioned media, as well as the amount of lubricin associated with cartilage surfaces (data not shown), accordant with other studies that document the upregulation of lubricin synthesis by ascorbic acid (Schmidt et al., 2004b) .
Dose-dependent effects of cytokines and growth factors on bovine chondrocyte lubricin mRNA expression
In agreement with the results described above, omission of ascorbic acid from cell culture medium reduced lubricin mRNA expression by bovine chondrocytes (Fig. 2) . For cultures maintained in the presence of ascorbic acid, inhibition of lubricin mRNA synthesis by IL-1 was observed at 10 ng/ml, whereas TGF-β-mediated enhancement of lubricin mRNA levels was apparent, occurring maximally (~4-fold) after stimulation at a concentration of 2 ng/ml. Lubricin mRNA expression was not observed to be significantly decreased in bovine chondrocyte monolayer cultures by TNF-α (100 ng/ml) or RA (1µM) treatments (data not shown), suggesting that the reductions in lubricin protein levels in response to these agents observed in cartilage cultures (see Fig. 1 ) might involve post-translational mechanism(s) of turnover/ degradation. In comparison, treatment of bovine chondrocytes for 24h with 2 ng/ml and 10 ng/ml OSM provoked a dose-dependent increase in lubricin mRNA expression (Fig. 2) , concordant with the effects of this cytokine on lubricin protein accumulation in bovine cartilage explants (Fig. 1 ).
Differential regulation of lubricin biosynthesis by human chondrocytes and synoviocytes
Stimulation of human chondrocytes and synoviocytes with 10 ng/ml IL-1 for 24h reduced lubricin mRNA levels bỹ 50-60% compared to untreated controls (Fig. 3) , and correlative changes were observed for lubricin protein secretion (Fig. 4) . TGF-β induced an increase in lubricin mRNA (~5-fold) and protein synthesis by both cell types. No significant effects on lubricin biosynthesis were observed following RA treatment, whereas TNF-α and OSM appeared to generate a cell-specific response in human chondrocytes and synoviocytes. Thus, TNF-α reduced lubricin expression by human chondrocytes, but not human synoviocytes, while OSM increased its synthesis in chondrocytes, but not synoviocytes (see Figs.  3 and 4) . Two different lubricin-specific primer/probe sets, targeting either exons 3/4 or exons 7/8, were used for the quantitative RT-PCR analyses (Fig. 3) , since previous studies have described alternative mRNA splice variants of the PRG4 gene (Flannery et al., 1999; Jay et al., 2001; Rees et al., 2002) . No significant differences were observed within treatment groups, however, when comparing the relative expression of these regions of lubricin mRNA. Quantitative RT-PCR analysis of lubricin mRNA expression by human chondrocytes (A) and synoviocytes (B). Cells were cultured for 24h in serumfree medium (+ 50 µg/ml ascorbic acid) in the absence (C, control) or presence of cytokines and growth factors as described in the legend to Fig. 1 . Two different lubricin primer/probe sets were used to generate and quantify amplicons derived from exons 3/4 or exons 7/8. Lubricin mRNA levels are expressed relative to the levels in control cultures. Values are the mean and standard deviation of 3 separate analyses. *Significantly different to control (P < 0.
05; Student's T-test). Lubricin bioregulation by growth factors/cytokines

Discussion
The synovial "tribosome", comprising macromolecules such as lubricin and aggrecan, facilitates lubrication and fluid pressurization of articular cartilage, thereby contributing to the maintenance of proficient joint functionality (Ateshian et al., 2003; Sah, 2004) . In addition to its localization at cartilage surfaces, lubricin occurs as a soluble component of synovial fluid, wherein it may reside as a boundary lubricant "reservoir", with the ability to (re)adhere at tissue interfaces . Dysregulation of lubricin metabolism, for example under the influence of elevated cytokine concentrations in diseased or damaged joints (Irie et al., 2003; Smith et al., 1997) , might thereby lead to lubrication deficiencies and loss-of-function.
Exposure of articular cartilage superficial zone chondrocytes, mandibular condyle cartilage and articular cartilage explants to IL-1 has previously been shown to downregulate the levels of secreted lubricin/SZP (Flannery et al., 1999; Jones et al., 2006; Khalafi et al., 2007; Ohno et al., 2006; Schmidt et al., 2004a) , through mechanisms which could include diminished expression as well as enhanced degradation/turnover. In the studies described herein, treatment of bovine articular cartilage explants with IL-1 decreased the levels of both cartilage surfaceassociated and soluble lubricin (Fig. 1) , and a similar effect on lubricin secretion occurred in human chondrocyte and synoviocyte cultures (Fig. 4) . A corresponding decrease in lubricin mRNA expression in response to IL-1 was also observed for cultured chondrocytes and synoviocytes (Figs. 2 and 3) , suggesting that transcriptional repression may, at least in part, modulate these effects. TNF-α and RA also reduced cartilage lubricin levels, however treatment with OSM, which is typically considered as a chondrodisruptive cytokine (Cawston et al., 1998; Hui et al., 1996) , enhanced the expression and accumulation of lubricin in cartilage explant and chondrocyte cultures, although synoviocyte lubricin synthesis in the presence of OSM was not apparently altered (see Figs. 1-4) .
Physiologically, lubricin contributes to capacitate cartilage with a remarkably low coefficient of friction (Jay, 2004) , and is involved in preventing cellular adhesion to cartilage surfaces (Rhee et al., 2005) . It will therefore be of considerable interest to further address whether changes in lubricin biosynthesis in response to growth factors and cytokines are reflected in relevant functional alterations (i.e. frictional properties). From a therapeutic perspective, it would appear that strategies to rescue lubricin dysfunction could be beneficial in the treatment of degenerative joint diseases such as OA. The upregulation observed for lubricin expression upon TGF-β stimulation, as demonstrated here and by others (Darling and Athanasiou, 2005; Flannery et al., 1999; Jones et al., 2006; Khalafi et al., 2007; Ohno et al., 2006; Schmidt et al., 2004a) , may advocate potential mechanisms for restoring lubricin deficiencies. Alternately, or additionally, cartilage endurance might also be enhanced by the induction of lubricin synthesis in response to appropriate biophysical stimuli (Grad et al., 2005; Grad et al., 2006; Nugent et al., 2006a; Nugent et al., 2006b; Wong et al., 2003) . The capacity for recombinant lubricin to effectively bind to, and lubricate articular cartilage surfaces (Gleghorn et al., 2006; suggests further evident therapeutic implications for delivery of applicable biolubricant formulations. . Cytokine-and growth factor-mediated regulation of lubricin secretion by human chondrocytes (A) and synoviocytes (B). Cells were cultured for 48h in serum-free medium (+ 50 µg/ml ascorbic acid) in the absence (C, control) or presence of cytokines and growth factors as described in the legend to Fig. 1 . Conditioned media were analyzed by Western blotting with a polyclonal anti-lubricin antibody, directed toward a peptide epitope encoded within exon 3 of human lubricin.
